| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | UNC0321 | CTRPv2 | pan-cancer | AAC | -0.0018 | 1 |
| mRNA | Axitinib | GDSC1000 | pan-cancer | AAC | -0.0018 | 1 |
| mRNA | tivantinib | CTRPv2 | pan-cancer | AAC | 0.0022 | 1 |
| mRNA | TAE684 | CTRPv2 | pan-cancer | AAC | 0.0016 | 1 |
| mRNA | GDC-0941 | FIMM | pan-cancer | AAC | 0.0085 | 1 |
| mRNA | decitabine | CTRPv2 | pan-cancer | AAC | -0.0012 | 1 |
| mRNA | C6-ceramide | CTRPv2 | pan-cancer | AAC | -0.0014 | 1 |
| mRNA | PLX4720 | GDSC1000 | pan-cancer | AAC | 0.0012 | 1 |
| mRNA | QL-XI-92 | GDSC1000 | pan-cancer | AAC | 0.001 | 1 |
| mRNA | BRD-K55116708 | CTRPv2 | pan-cancer | AAC | -0.0012 | 1 |